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RESEARCH ARTICLE
An eQTL in the cystathionine beta synthase 
gene is linked to osteoporosis in laying hens
Dirk‑Jan De Koning1, Nazaret Dominguez‑Gasca2, Robert H. Fleming3, Andrew Gill3,7, Dominic Kurian3, 
Andrew Law3, Heather A. McCormack3, David Morrice3, Estefania Sanchez‑Rodriguez2, 
Alejandro B. Rodriguez‑Navarro2, Rudolf Preisinger4, Matthias Schmutz4, Veronica Šmídová3,6, Frances Turner3, 
Peter W. Wilson3, Rongyan Zhou3,5 and Ian C. Dunn3* 
Abstract 
Background: Skeletal damage is a challenge for laying hens because the physiological adaptations required for egg 
laying make them susceptible to osteoporosis. Previously, we showed that genetic factors explain 40% of the variation 
in end of lay bone quality and we detected a quantitative trait locus (QTL) of large effect on chicken chromosome 1. 
The aim of this study was to combine data from the commercial founder White Leghorn population and the F2 map‑
ping population to fine‑map this QTL and understand its function in terms of gene expression and physiology.
Results: Several single nucleotide polymorphisms on chromosome 1 between 104 and 110 Mb (galGal6) had highly 
significant associations with tibial breaking strength. The alternative genotypes of markers of large effect that flanked 
the region had tibial breaking strengths of 200.4 vs. 218.1 Newton (P < 0.002) and, in a subsequent founder genera‑
tion, the higher breaking strength genotype was again associated with higher breaking strength. In a subsequent 
generation, cortical bone density and volume were increased in individuals with the better bone genotype but with 
significantly reduced medullary bone quality. The effects on cortical bone density were confirmed in a further genera‑
tion and was accompanied by increased mineral maturity of the cortical bone as measured by infrared spectrometry 
and there was evidence of better collagen cross‑linking in the cortical bone. Comparing the transcriptome of the tibia 
from individuals with good or poor bone quality genotypes indicated four differentially‑expressed genes at the locus, 
one gene, cystathionine beta synthase (CBS), having a nine‑fold higher expression in the genotype for low bone qual‑
ity. The mechanism was cis‑acting and although there was an amino‑acid difference in the CBS protein between the 
genotypes, there was no difference in the activity of the enzyme. Plasma homocysteine concentration, the substrate 
of CBS, was higher in the poor bone quality genotype.
Conclusions: Validated markers that predict bone strength have been defined for selective breeding and a gene was 
identified that may suggest alternative ways to improve bone health in addition to genetic selection. The identifica‑
tion of how genetic variants affect different aspects of bone turnover shows potential for translational medicine.
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
Bone fractures and other forms of skeletal damage are a 
challenge for laying hens [1] and are the result, at least 
in part, of progressive osteoporosis [2]. Osteoporosis in 
hens is ultimately the result of the physiological changes 
that occur because of the start of reproductive activity. 
At this stage, the hen starts to form medullary bone [3], 
which is a specialised bone formed as an adaptation for 
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laying a calcareous cleidoic egg. Medullary bone provides 
a reserve of calcium for mineralisation of the eggshell and 
it is very labile, turning over rapidly with the daily cycle 
of egg laying [3]. This rapid turnover is characterised, as 
in the structural cortical bone, by osteoblastic and osteo-
clastic remodelling [4, 5], but there is a rapid change in 
the rate of mineralisation that depends on the stage of 
shell calcification. Osteoblast activity in structural corti-
cal bone at this time is minimal, since resources transfer 
to the medullary bone while osteoclast bone resorption 
continues. Overall, this is thought to lead to a reduction 
in the integrity and mass of the structural bone over the 
period of laying, which can be exacerbated by any imbal-
ance in calcium supply from the diet [6]. These factors 
are in turn predictive of breaking strength [7], which in 
turn are predictive of likelihood of fracture or deforma-
tions [8, 9].
Whereas undoubtedly housing and nutrition must be 
optimised to ensure good bone health in laying hens, we 
believe that genetics offers an important route to reduce 
bone fractures [10], especially with the increased chal-
lenges to hen welfare posed by alternative housing [1]. 
We have shown that genetics has a clear potential to 
improve bone health without detriment to production 
traits: in our previous work, we found that genetic fac-
tors underlie the variation in the susceptibility of indi-
vidual birds to osteoporosis and bone fracture [8]. Some 
studies have described quantitative trait loci (QTL) for 
bone quality in chickens related to osteoporosis, usually 
from crosses of radically different breeds in which body 
mass can be an issue [11–13], but few have looked within 
a commercially relevant layer population as investigated 
here. Divergent selection from a commercial pedigree 
founder breed on the basis of a bone index (BI), which 
comprises several bone strength and other traits, resulted 
in the production of high (Hi) and low (Lo) bone strength 
lines of laying hens, but with no change in body weight 
[8]. Selection resulted in the Hi line showing an improve-
ment in tibia strength of over 50%, without any adverse 
effect on egg production or egg quality. The bones of 
the hens from the Hi bone strength line have fewer 
osteoclasts, and consequently suffer less bone resorp-
tion during the laying period, resulting in a lower rate 
of endosteal cortical bone loss and greater accumulation 
of medullary bone than those from the Lo line [10]. In 
these hens, there were differences in the degree of colla-
gen cross-linking [14]. Pyrrolic cross-link content of col-
lagen, known to be correlated with osteoporosis in hens, 
was higher in the humerus and tibiotarsus of the Hi line 
selected hens [15]. Using an F2 population created from 
the Hi and Lo lines, a QTL of large effect was character-
ised on chicken chromosome 1 [16]. In the work reported 
here, we have fine-mapped this QTL and combined the 
data with next-generation sequencing of RNA from the 
bones of hens segregating for markers of the QTL. Ulti-
mately, the genetic markers identified can be used to 
select for better bone strength, which will reduce the pro-
pensity for osteoporosis and, in turn, bone breakage. Few 
of the many QTL detected in GWAS studies for human 
osteoporosis have been functionally characterised [17]. 
Understanding the potential underlying causes that can 
be deduced from the identification of the genes involved 
in this QTL may lead to understanding the causes of 
osteoporosis, suggest new management or nutritional 
solutions for hens, and potentially lead to a better under-
standing of bone loss in other species.
Methods
Populations of White Leghorn chickens used to fine‑map 
the QTL for bone strength and understand its function
Population 1
Population 1 was an F2 population (n = 372) that was 
described previously [16]. It was created by crossing high 
and low bone quality lines produced by divergent selec-
tion of the founder breed [8, 16] (Fig.  1). The QTL on 
chromosome 1 was originally discovered in this popula-
tion. The population was used to improve the precision 
of the location of the QTL with informative single nucle-
otide polymorphisms (SNPs) at the locus. The measured 
phenotype was tibial breaking strength and genotyping 
was performed with microsatellite markers as described 
previously [16] and SNPs that are listed in Additional 
file 1: Table S1.
Population 2
Population 2 was a later generation (sampled in 2006, 
see Fig.  1) of the founder breed used to generate the 
divergently selected population that was used to cre-
ate the F2 population where the QTL was discovered 
[16]. It is a White Leghorn breed used in the produc-
tion of LSL hybrid layers (Lohmann Tierzucht GmbH). 
With the ability to obtain high-density genotyping and 
a larger number of animals, the population allowed bet-
ter precision for mapping the QTL. As in all the popula-
tions for which bones were measured in this study, hens 
were housed in individual cages to facilitate egg record-
ing. Phenotype for tibia breaking strength, body weight 
and egg production were available for 1595 hens. DNA 
was prepared from red blood cells using DNAzol (Invit-
rogen). Hens were genotyped for 144 SNPs as described 
in the section on genetic markers below and in Addi-
tional file  2: Table  S2. To increase power and reduce 
cost only the top and tail of the population were gen-
otyped. Bone strength is influenced by body weight in 
hens, as witnessed by its negative weighting in the bone 
index used to divergently select hens that formed the 
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founder population for the QTL analysis [8]. For this 
reason and to avoid biasing the sample towards heav-
ier and lighter hens, we chose to select equal numbers 
of hens from the top and tail of the distribution of the 
population after ranking the hens using the residuals 
generated after fitting body weight using regression 
analysis. The equation derived from the data was tibia 
breaking strength (N) = 53.0 + 0.0946 body weight (g). 
Hens laying less than 230 eggs were removed, since 
these can have stronger bones and do not form part 
of the normal distribution, as was done in the original 
QTL study [16]. Equal numbers of individuals from the 
top and the tail of the population were selected and 998 
animals were genotyped. This represented 63% of the 
population. The phenotype was tibial breaking strength 
and genotyping was performed with 144 SNPs on chro-
mosome 1.
Further studies were undertaken and samples were 
collected from the founder breed in subsequent years to 
characterise the locus and its effects.
Population 3
Samples (n = 111) for genotyping and phenotyping were 
taken from the 2010 generation (Fig.  1) of the founder 
breed using a targeted sampling approach, which was 
used to provide further independent confirmation of 
the locus effect. As in the other populations, only hens 
laying more than 230 eggs were analysed. To obtain the 
best power with the resources available, samples were 
collected only from hens at post-mortem if, after being 
9 
generaons
• Founder populaon used for divergent selecon based on bone index [8]. The 
divergently selected lines  were used to generate the  F2 populaon used to 
discover the QTL fine mapped and characterised in this paper.    
5 
generaons
• Populaon 2; 2006, n=1595, measurement of bia breaking strength.  458 
individuals genotyped for hundred and forty four SNP s  on chromosome 1. 
1 generaon
• Populaon 3; 2010, n=111, measurement of bia 
breaking strength. Genotyped for SNP Ost112522587 and 
Ost106225194  on chromosome 1.
1 generaon
• Populaon 4; 2012, n=58, measurement of corcal and medullary bone density and 
volume, mid sha bia bone RNA which was used for RNA seq and  CBS allelic 
imbalance. Genotyped for SNP Ost112522587 and Ost106225194  on chromosome 1.
• Populaon 5; 2013, n=66, measurement of Plasma homocysteine, bia  breaking 
strength, corcal and medullary bone density and volume, physiochemical 
measurements. Genotyped for SNP Ost112522587 and Ost106225194  on 
chromosome 1.
Populaon 1; F2 populaon  [16]. n=372, 
measures of bia and humerus breaking 
strength and keel density
Fig. 1 Schematic diagram of the populations used for fine mapping and characterising a QTL for bone quality on chromosome 1. Numbers of 
generations between the populations are indicated to the left and the year, number of animals, phenotypes and genotypes are in the text boxes to 
the right
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tested for breaking strength, the bones were more than 
1.5 standard deviations from their predicted breaking 
strength (PBS). PBS was calculated using a training set 
of 200 hens. The equation was produced by regressing 
tibial breaking strength against body weight and total 
egg production. (PBS = 90.5 + (− 0.687 egg produc-
tion) + (0.1239 bodyweight)). The distribution of the 
‘residual’ between the observed and predicted breaking 
strength based on the 200-hen training set was used to 
define 1.5 standard deviations. This ensured that we did 
not bias the results since larger hens have stronger bones 
and hens that lay significantly fewer eggs due to pauses in 
production can have stronger bones as do out-of-lay hens 
[18]. Hens with four or less follicles or with any evidence 
of reproduction abnormality such as internal ovulations 
were rejected at post-mortem. The phenotype was tibial 
breaking strength and genotyping was performed with 
the Ost106225194 and Ost112522587 SNPs.
Population 4
Samples of mid-shaft tibia bone were collected from 
the 2012 generation (Fig. 1) for the preparation of RNA 
for next-generation sequencing (NGS) and to make 
bone density measurements. This allowed the charac-
terisation of expression differences related to the QTL. 
Thirteen sires and 50 dams were genotyped for SNPs 
Ost106225194 and Ost112522587 and offspring from 
heterozygous individuals were prioritised for the detec-
tion of homozygotes by genotyping the same mark-
ers. Homozygous hens (n = 34 AA/AA; n = 22 GG/GG) 
were phenotyped at the end of their productive cycle at 
70 weeks of age. RNA was prepared from mid-shaft tibia. 
The measured phenotype was mid-shaft cross-sections 
of tibia that were taken for radiographic measurement 
of cortical and medullary bone density, volume and area. 
The animals used for NGS of bone RNA were selected 
from these (see section on NGS). Genotyping was per-
formed with Ost106225194 and Ost112522587 SNPs.
Population 5
Samples were obtained from the 2013 generation (n = 66) 
using the same sampling strategy as for Population 4, but 
samples were collected for evaluating specific properties 
of bone material at 70  weeks of age to understand how 
the genotype might result in the observed bone strength 
phenotype (Fig.  1). The measured phenotype was con-
centration of homocysteine in the plasma towards the 
end of peak egg production (48  weeks of age) and end 
of production (70  weeks of age). A subset of these ani-
mals, n = 19 per genotype, with matching physiology 
with regard to stage of egg formation were further ana-
lysed for bone mechanical properties, bone microstruc-
ture, chemical composition of the cortical and medullary 
bone, mineral crystallinity and crystal orientation and 
collagen maturity using infrared spectroscopy and X-ray 
diffraction techniques. Genotyping was performed with 
Ost106225194 and Ost112522587 SNPs (n = 33 AA/AA; 
n = 33 GG/GG).
Population 6
Population 6 was a White Leghorn line that was not 
related to the other populations. We used it to provide 
material for the measurement of CBS enzyme activity as 
described in the respective sub-section. It consisted of 
embryos from a White Leghorn population maintained 
at the Roslin Institute, which was found to carry the SNP 
rs316554658 that resulted in a predicted amino acid dif-
ference. Sires and dams heterozygous for this SNP were 
bred and the resultant eggs were incubated. At day 15, the 
embryo livers were harvested and stored at -20 °C prior 
to use in the assay, and a sample of blood was taken for 
DNA preparation to confirm the genotype of the embryo. 
The measured phenotype was CBS enzyme kinetics and 
genotyping was done with SNP rs316554658.
Genetic markers
For fine mapping, SNPs in the QTL region were sourced 
in a number of ways. SNPs were sourced from dbSNP 
[19] along chicken chromosome 1 for use in the F2 cross. 
A more targeted set of SNPs was defined from sequence 
information [20] from White Leghorn breeds between 
81.1 and 128.8  Mb on chromosome 1 (galGal6). This 
corresponded to the 95% confidence interval (CI) of the 
original QTL. The number of SNPs was reduced from 
91,455 to 15,761 by using only those segregating in all the 
sequenced breeds, and finally to 193 using those that had 
a minor allele frequency (MAF) lower than 0.2 in all three 
breeds. This list was reduced furthermore by removing 
SNPs in close proximity to each other and by biasing the 
density to be higher at the perceived peak and reduced at 
the tails of the region. Around 25 SNPs failed the test for 
ability to construct an Illumina Golden Gate assay. The 
SNP list was supplemented by SNPs that were derived 
from the alignment of EST sequences from the following 
genes located in the target region: RGN, EFHC2, EGFL6, 
DMD, PHEX, AGPAT3, PRDM15, MX1, PIGP, MRPS6, 
DDX3X, RPL8, ATP6AP2, PDK3 and APOO. The full list 
of genotyped SNPs is in Additional file 2: Table S2. One 
hundred and forty-four SNPs were genotyped on Popula-
tion 2 using the Illumina Golden Gate assay on the Illu-
mina BeadXpress platform. The Illumina Bead Studio 
Genotyping Module software was used to analyse SNP 
data and, as a first quality control, to remove poor qual-
ity or uninformative SNPs. From the 119 SNPs obtained 
from sequence data, only 13 were informative in the F2 
cross, whereas in the case of the SNPs discovered using 
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EST sequences, 19 out of 39 were informative. The 95% 
CI of the QTL was chr1: 75,624,794-124,047,308 bp (gal-
Gal6) and the region covered by the new markers was 
chr1: 77,312,158-124,272,094 with an average distance of 
0.336 Mb (SD 0.183) between SNPs.
For Population 1, the 32 informative SNPs from those 
detailed above were genotyped using the Illumina Golden 
Gate assay on the Illumina BeadXpress platform. The 
Bead Studio Genotyping Module software was used to 
analyse SNP data. These SNPs were added to the genetic 
map for chromosome 1 to determine the QTL position 
in the F2 Population 2. The new F2 map is in Additional 
file  1: Table  S1. The map was used as previously [16] 
using the QTL mapping method of Haley et al. [21] but 
implemented using gridQTL [22].
Small‑scale genotyping
Genotyping with SNPs Ost112522587 and Ost106225194 
to define parents or individuals for Populations 3, 4 and 5 
with the desired genotype was carried out by LGC (LGC, 
Middlesex, UK), assay reference Chr1_112522587200 and 
Chr1_1062251946, respectively.
SNP rs316554658, which was predicted to result 
in an amino-acid change, was diagnosed using RFLP 
after amplification with primers CBS_NS_F (5′ CGT 
CTG GTG AAG GGG AAT AA 3′) and CBS_NS_R (5′ 
TCC CTT TTC AGC TGC TCA GT 3′). This resulted 
in an amplified product of 596  bp using genomic DNA 
as target (Chromosome 1, 106,922,247–106,922,842). 
When digested with the restriction enzyme HpyCH4V, 
the amplification of allele C gives products of 289, 166, 
93 and 48  bp (the restriction site at position 289 in the 
PCR product is part of a codon for Q at position 498 in 
the CBS protein, therefore CC). Digestion of the allele A 
product (part of a codon for K at position 498 in the CBS 
protein) gives digestion products of 382, 166 and 48 bp. 
This was used to genotype Population 6 to allow identi-
fication of individuals that differed in their CBS amino 
acid sequence and to collect tissue to assess the function 
of the enzyme.
RNA seq
Mid-shaft tibia bone total RNA samples were prepared 
from 70-week old hens from Population 4 for which the 
egg was in the shell gland to reduce any effect of the egg 
calcification cycle. RNA was prepared using the TRI-
zol reagent according to the manufacturer’s instruc-
tions (Invitrogen Ltd., Renfrewshire, Scotland). RNA 
was treated with DNAse I and purified using an RNeasy 
Mini Kit following the manufacturer’s instructions (Qia-
gen, Manchester, England), concentration and quality 
were checked with a Nanodrop ND-1000 spectropho-
tometer (Thermo Scientific; Waltham, MA USA). Half of 
the samples were homozygous for the low bone breaking 
strength genotype (n = 8) and the other half (n = 8) were 
homozygous for the high bone breaking strength geno-
type. Total RNA samples (1 µg) were prepared for mRNA 
sequencing using the Illumina Truseq RNA Sequencing 
protocol. Resulting libraries were quality-checked on an 
Agilent DNA 1000 bioanalyzer (Agilent Technologies, 
South Queensferry, UK) and then clustered onto a paired 
end flowcell using the Illumina v3 cluster generation kit 
at a concentration of 8  pM. One hundred cycle paired-
ended sequencing was carried out on the HiSeq  2000 
using Illumina v2 Sequencing by Synthesis kits (Illu-
mina, Little Chesterford, UK). An Illumina HiSeq  2000 
platform at Edinburgh Genomics generated between 40 
and 60 million RNAseq reads per sample (819 million in 
total). Quality control of the raw data was evaluated using 
the FastQC package [23] (Babraham bioinformatics, 
Cambridgeshire, England). Reads were adapter-trimmed 
using cutadapt version 1.3 [24] with the parameters-q 
30-m 50-a AGA TCG GAA GAG C. Differential expression 
of genes or tags was assessed using edgeR version 3.6.8 
[25], a package in the bioconductor suite [26] imple-
mented in R [27]. The likelihood that the expression of 
genes differed between the genotypes was estimated 
using a general linear model in the edgeR package. Genes 
with a false discovery rate less than 0.05 were reported 
as of interest. A fuller version is available in Additional 
file 3. The data were submitted to the European nucleo-
tide archive (study accession PRJEB6782) and have been 
used in the annotation of the chicken genome [28].
Examination of genes of interest using the NGS data 
was performed manually using Tablet v1.17.08.17 [29] 
to ascertain the location of polymorphisms in each bird 
and these were annotated to the sequence using Seqbuild 
(DNASTAR, Inc. Madison, WI). Assembly of short reads 
to produce the CBS mRNA sequence was made using 
Staden Gap5 v1.2.14-r [30].
The CBS gene
Understanding the CBS gene in the chicken: sequence 
and variant expression
The CBS gene is considered to be present in the chicken 
genome based on a prediction. It has the Ensembl 
transcript ID ENSGALT00000026110 at position 
chr1:111,011,700–111,029,467 (galGal6). Another gene 
shares sequence similarity in some of the exons with 
CBS and is named the CBS-like gene (CBSL); it has the 
Ensembl transcript ID ENSGALT00000026104 and is 
located upstream from CBS at position chr1:110,980,772–
110,999,637 (galGal6). ENSGALT00000026110 and 
ENSGALT00000026104 are 1836  bp and 1938  bp long, 
respectively, and the identity over the regions that align is 
equal to 73.5% (1106/1505) with 14 gaps using ‘Matcher’ 
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in mEMBOSS [31]. The sequences differ sufficiently for 
defining specific PCR assays to investigate their relative 
expression.
CBS quantitative PCR
CBS gene expression was measured using quantita-
tive PCR (qPCR); a standard curve was used to quantify 
expression of CBS and measurements were standardised 
using the lamin B receptor (LBR) as reference gene, the 
expression of which did not differ between genotypes 
(P = 0.585). The overall methodology for quantification 
was as previously described in [32, 33].
cDNA for measurement was prepared from mid-shaft 
tibia samples from the Ost112522587/Ost106225194, 
AA/AA (n = 36) and GG/GG (n = 25) genotypes from 
Population 4. Because two versions of the gene appear 
to exist in the chicken genome as stated above, CBS and 
CBSL, we measured both to confirm which gene was dif-
ferentially expressed. In the process, we established that 
the CBSL gene was not highly expressed using the ΔΔct 
method [34] to estimate the fold difference in expression 
of the two genes in the same samples. The CBS primers 
for qPCR avoided polymorphisms that were known to 
be within the locus: CBS-F2a, TTG GGC TGA AGT GTG 
AAC TC; CBS-R2, TCA GGA CAT CCA CCT TCT CC; 
product length 233 and for CBSlikeF2, GCT CCG GAG 
TCT AAC ATT CG; CBSlikeR, ATC ACC ACC ATG TGG 
ACC TT product length 164 bp. Using 16 samples of RNA 
extracted from mid-shaft tibia bone for NGS, which rep-
resented eight samples of each genotype (Ost112522587/
Ost106225194, AA/AA vs. GG/GG) that were in the 
same reproductive state, the version of CBS represented 
by ENSGALT00000026110 was expressed on average 
815 ± 157-fold higher than CBSL when calculated from 
the quantitative PCR data. For this reason, we confined 
subsequent measurements to the CBS gene.
CBS allelic imbalance
Allelic imbalance of CBS expression in hens that were 
heterozygous at the Ost112522587 SNP from Population 
4 was determined by amplification of cDNA derived from 
bone of 10 heterozygous hens using primers CBSgenoF1, 
GTG GAA CGT CAG TGT TCA GG; CBSgenoR1, AAG 
GCT GAA CTT TTC CAG CA followed by digestion with 
HpyCH4V restriction enzyme. This yields DNA products 
of 132 and 68 bp for the A allele associated with low bone 
strength or leaves the fragment uncut at 200  bp for the 
B allele associated with high bone quality. Products were 
run on a 3% agarose gel containing Sybrsafe (Invitrogen, 
Paisley, Scotland). The intensity of the bands was calcu-
lated using ImageJ 1.32 (http://image j.nih.gov/ij/) on 
images taken using a G:Box imager (Syngene, Cambridge, 
UK). The sum of the intensity of the 132-bp and 68-bp 
band was compared with the 200-bp band intensity 
expressed as a fraction of the total area under the curve 
using a paired t test.
CBS enzyme activity assay in livers of embryos expressing 
protein from allelic variants
A coding variant was detected at position 498 in CBS 
coding for glutamine (Q) or lysine (K) giving rise to 
two allozymes. Estimation of the activity of CBS in liver 
expressing the protein that contains these alternative 
amino-acids was based on the production of cystathio-
nine in the presence of varying substrates (L-homocyst-
eine 0.1–5  mmol/L, serine constant at 5  mmol/L) and 
cofactors (S adenosylmethionine 200  µmol/L and pyri-
doxal phosphate 50  µmol/L [35]. All reagents were 
obtained from Sigma-Aldrich. In brief, liver samples from 
day-15 embryos harvested from Population 6, which seg-
regated for the alternative alleles, were homogenized 
(Ultraturrax, IKA-Werke GmbH & Co. KG, Germany) 
in an extraction buffer containing protease inhibitor. 
Protein concentrations of the homogenate supernatant 
were estimated using a Pierce™ Coomassie blue assay 
(Thermo Fisher, UK) and 100 µg of protein was included 
in the assay in a total volume of 50 µl and incubated for 
1 h at 37 °C. Finally, 150 µl of acetonitrile (VWR Chemi-
cals Leicestershire, UK) was added to precipitate proteins 
and the supernatant retained for liquid chromatography–
mass spectrometry (LC–MS) measurement, see below. 
The Michaelis–Menten constant (Km) and the maxi-
mum activity (Vmax) were estimated by plotting a double 
reciprocal plot using the rate of cystathionine production 
at each homocysteine concentration; 50, 40, 30, 20, 10, 5, 
2 and 1 mM.
Measurement of homocysteine and cystathionine using LC–
MS
LC–MS measurements for homocysteine and cystathio-
nine levels in samples from the CBS enzyme activity 
assay were performed by a selected reaction monitoring 
assay on an amaZon ETD IonTrap Mass spectrometer 
(Bruker Daltonics, GmbH, Bremen, Germany) coupled 
to an Ultimate HPLC (Dionex) system, for more details 
(see Additional files 3 and 4). In addition, the method was 
used to measure plasma homocysteine for validation of 
the commercial kit as described below.
Plasma homocysteine measurement
Plasma homocysteine was measured using the kit 
HY4036 (Randox laboratories, County Antrim, UK) 
based on enzymatic conversion of homocysteine to cys-
tathionine by CBS. Plasma was treated prior to measure-
ment with lipoclear (Vetlab supplies, West Sussex, UK) to 
remove circulating lipids. In humans, the homocysteine 
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assay relies on low endogenous levels of circulating cys-
tathionine to work, but it was not clear if this was true in 
chickens. To ascertain if concentrations measured by the 
kit were the same as those measured using LC–MS, a set 
of samples was measured by both methods. Comparison 
of the respective measurements resulted in an R-squared 
value of 92%, which suggested that the biochemical 
method worked adequately to detect homocysteine in 
chicken plasma.
Bone material properties
Breaking strength
Among the main morphological and biomechanical 
properties, tibia breaking strength was determined by a 
three-point bending test using a material testing machine 
(JJ Lloyd LRX50, Sussex, UK) as previously described [7].
Radiographic density
Cross-sections of the tibia bone were radiographed in 
a Faxitron 43855D soft X ray apparatus using Kodak 
MRE-1 high-resolution mammography film in Min-R2 
cassettes with a single Min-R intensifying screen. Each 
exposed plate included a 16-step aluminium wedge, with 
0.25-mm increments, for calibration purposes. Exposed 
films were developed using an automatic processor and 
then digitised using a Kodak LS-75 film scanner. Meas-
urement of the radiographic density and proportion of 
medullary and cortical bone in the tibia was made using 
the software package ImageJ 1.32 (http://rsb.info.nih.gov/
ij/). Each tibia bone was automatically delineated from 
the background and the mean radiographic density (pre-
calibrated in mm of aluminium equivalent) of the whole 
bone was measured. The proportion of medullary and 
cortical bone type was calculated directly from the X-ray 
by delineation [36].
Bone chemistry and structure
Bone samples: Tibia bones were stored in a freezer at 
− 20 °C until analysed for bone physicochemical material 
specific properties (e.g., bone microstructure, chemical 
composition of the cortical and medullary bone, min-
eral crystallinity and crystal orientation, and collagen 
maturity) using infrared spectroscopy and X-ray diffrac-
tion techniques as fully described in Additional file 3 and 
briefly below.
Infrared spectrometry: The chemical composition of 
bone tissues (cortical and medullary bone) were analyzed 
by infrared spectroscopy as previously described [37]. 
The relative amounts of water, proteins (collagen), lipids, 
phosphate and carbonate in the bone samples were 
determined from the peak area of the absorption bands 
associated with the characteristic molecular groups of 
each component [38, 39]. In addition, the absolute water, 
organic matter, carbonate and phosphate contents in 
bone were determined by thermogravimetry (TGA) in 
selected samples. For these analyses, about 25 mg of the 
powdered bone were introduced into a crucible and ana-
lysed using a TGA system from METTLER-TOLEDO 
(mod. TGA/DSC1). A heating rate of 20 °C/min was used 
for registering the TGA curves.
X-ray diffraction: Tibiae cortical bone (about 1 × 1 cm) 
samples cut from the diaphysis were analyzed in trans-
mission mode with a single crystal diffractometer 
equipped with an area detector (D8 SMART APEX from 
Bruker) and Mo radiation (50 kV and 30 mA; 0.5 mm col-
limator). A quantitative estimation of the degree of ori-
entation of apatite crystals (Angular spread; AS) in the 
cortical bone was determined from the angular breadth 
of bands displayed in the intensity profile along the 
Debye–Scherrer ring associated with the 002 reflection of 
apatite mineral [37].
Results
Fine mapping
Improved resolution of the QTL in Population 1
To improve the resolution in Population 1, which is the 
original F2 used to detect the QTL on chromosome 1, 
27 new informative markers from those used on Popu-
lation 2 were added to the original map. The F value for 
the QTL improved from 13.2 in the original publication 
to 16.0 for the tibial breaking strength trait, from 7.9 to 
10.9 for humeral breaking strength, and from 9.3 to 12.3 
for the bone index compound trait. Overall, the position 
of the QTL became more consistent at 363–365 cM com-
pared to the original estimates and the 95% confidence 
interval decreased (Table 1).
When the most significant SNP from the association 
study was fitted as a covariate, the QTL effect was in 
great part removed (Fig. 2).
Identification of the functional consequences of the QTL
Trait values and marker association in Population 2
For Population 2, the 2006 generation of the study pop-
ulation, which was measured at 70  weeks of age, egg 
production, body weight and tibia breaking strength 
(mean ± SD) of the population were equal to 240.9 ± 10.9 
eggs, 1623 ± 162 g and 206.5 ± 42.1 Newton, respectively 
(n = 1595).
The results of the association analysis using the 32 
SNPs that segregated at the QTL are in Table  2. The 
average effect size for markers with significant effects is 
around 15 Newton between the homozygotes with the 
additive effect representing half this value. The alterna-
tive combined genotypes for the most significant SNPs 
of large effect and flanking the region (Ost112522587/
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Ost106225194; AA/AA vs. GG/GG) had tibial breaking 
strengths of 200.4 vs. 218.1 Newton (P < 0.002).
Population 3: identifying the functional consequences
In 2010, the founder population (Population 3) was re-
sampled and 111 individual hens were identified that 
differed in their predicted versus their observed tibial 
breaking strength by more than 1.5 of a standard devia-
tion in each direction. When subsequently markers for 
bone quality were identified (Table  2), these individu-
als were genotyped for two of the markers with a large 
effect that flanked the region (SNPs Ost112522587 and 
Ost106225194). Hens segregating for the Ost112522587 
genotype displayed a large difference in tibial breaking 
strength although the high bone strength genotype was 
poorly represented in the sample; A:A, 198.4 ± 7.2 New-
ton, N = 83; G:A, 225.3 ± 13.4 Newton, N = 26; and G:G, 
261.7 ± 27.1 Newton, N = 2. This difference was signifi-
cant when fitting body weight as a covariate (P = 0.04) 
and represents an additive effect of about 32 Newton. 
There was no significant difference in body weight, egg 
breaking strength, or egg number between genotypes. 
The size of the effect may have been inflated by the selec-
tion procedure for the top and tail distribution of bone 
strength.
Expression analysis of bone from Population 4
With the identification of predictive markers, it was 
possible to prioritise families, which were likely to con-
tain offspring that would be homozygous at the markers 
Table 1 Estimates of  the  position of  the  bone quality QTL located on  chromosome 1 in  hens of  an  F2 reciprocal 
cross between White Leghorn hens divergently selected for bone index
The values in brackets represent the values found in the original analysis [16]
a Positions in Mb on the chicken genome galGal6 build were calculated from the position of the flanking markers on the 2011 (galGal4) build, then updated using 
Liftover
Trait Position (cM) 95% CI (cM) F statistic Flanking markers aPosition (Mb)
Tibiotarsal breaking strength 363 (370) 348–402 (138–416) 16.2 (13.2) ROS0081 ADL0148 111.2–113.1
Humeral breaking strength 365 (343) 129–381 (30–376) 11.1 (7.9) ADL0268‑MCW0061 90.2–90.2
Bone index 364 (364) 325–401 (198–393) 12.3 (9.3) Ost109151638‑ADL0148 107.0–113.1
Posion on GGA1 (cM) 
Ev
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F 
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QTL for bia strength
Fig. 2 Evidence for a QTL affecting bone strength in an F2 population on chicken chromosome 1 (solid line) and with the most significant SNP 
from the association study fitted as a covariate (dashed line)
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by genotyping the parents (Population 4). Individuals 
homozygous at Ost106225194 and Ost112522587 did 
not differ for body weight or eggshell strength (Table 3). 
The cortical density and cortical bone volume were 
greater, although not significantly (P = 0.09 and 0.06, 
respectively), in the group associated with the high 
bone strength genotype (GG/GG). However, the most 
striking difference was for the medullary bone. The 
medullary area and volume were smaller, but the med-
ullary bone was denser in the high bone strength geno-
type (Table 3).
To understand what expression differences may exist 
between the genotypes at the QTL, eight hens from each 
homozygous genotype were selected for transcript pro-
filing by NGS. The hens were a sample of the popula-
tion represented in Table 3. As in the whole population, 
there was no difference in body weight or egg production 
and all hens had an egg in the same position in the shell 
gland. Analysis of the RNAseq data highlighted five genes 
that were significantly differentially expressed between 
the genotypes using a nominal FDR of 0.05 (Table  4). 
All of these differentially expressed genes mapped to the 
Table 2 Significance of  association between  SNPs on  chromosome 1 and  tibial breaking strength in  hens at  70  weeks 
of age
F values were obtained by REML analysis with body weight, hatch, total eggs and eggs in the 3 days before death as fixed effects, and sire and dam as random effects. 
Effect sizes are quoted relative to the reference homozygote only for the SNPs that had a nominal significance level lower than 0.05. If corrected for multiple testing 
and taking the identification of seven blocks containing 23 SNPs using Haploview [40] into account, then the significance after Bonferroni correction should be set at 
0.003. The SNPs passing this threshold are in italic characters. The additive effect represents half that of the homozygote reference
Marker name GalGal6 chr 1 position 
(bp)
F statistic P value Heterozygote effect 
(Newton)
Homozygote 
effect (Newton)
Ost92365348 90,332,842 0.22 0.802
Ost99883015 97,883,872 1.6 0.203
Ost101413556 99,395,470 2.04 0.131
Ost106225194 104,084,042 7.45 < 0.001 6.08 16.02
Ost106460620 104,314,846 2.88 0.057
Ost106823022 104,678,816 3.85 0.022 12.77 2.62
Ost106940170 104,834,987 4.9 0.008 6.336 17.15
Ost107389494 105,280,127 6.3 0.002 13.2 − 1.65
Ost107766125 105,655,660 5.58 0.004 12.61 4.83
Ost108015093 105,901,013 5.59 0.004 12.69 4.82
Ost109151638 107,036,767 3.17 0.042 − 7.75 − 16.75
Ost109151769 107,036,898 3.17 0.042 9.00 16.75
Ost110373245 108,261,209 3.18 0.042 − 0.58 − 8.29
Ost110455031 108,342,396 5.49 0.004 6.59 18.46
Ost112374543 110,246,492 3.51 0.03 − 2.98 − 12.63
Ost112522587 110,393,717 6.34 0.002 9.92 16.55
Ost113740421 111,546,531 1.59 0.205
Ost113743229 111,549,338 1.29 0.276
Ost114648871 112,392,632 0.99 0.372
Ost115611476 113,329,344 3.66 0.026 − 3.8 − 11.13
Ost115617544 113,335,412 0.44 0.647
Ost115655839 113,373,156 2.47 0.085
Ost115861595 113,578,876 1.97 0.14
Ost115862305 113,579,586 1.78 0.17
Ost115865281 113,582,562 1.4 0.248
Ost115866264 113,583,545 0.16 0.92
Ost121757410 119,732,454 0.2 0.821
Ost121237272 119,214,984 6.19 0.013 − 7.67
Ost126455926 124,863,293 0.27 0.601
Ost129219873 126,721,130 5.68 0.004 − 46.2 − 61.66
Ost134239048 131,424,865 0.14 0.872
Ost134239237 131,425,054 0.14 0.872
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refined QTL that define good and poor bone strength, 
with the exception of the gene on chromosome 4, (Fig. 3, 
and Table 4). In addition, with the exception of the gene 
on chromosome 4, they were expressed at a higher level 
in the low bone strength genotype. The most significant 
transcript, CBS, had a P value of around one order of 
magnitude greater than that of any of the other gene tran-
scripts that passed the significance threshold (Table 4).
The differential expression of CBS was confirmed 
(P < 0.001) by qPCR in a larger population of birds includ-
ing the animals used in the NGS represented in Table 3. 
The expression of the CBS gene was 10.2 ± 1.2 × 10−12 
(n = 36) in the low bone strength genotype (AA/AA) vs. 
3.4 ± 0.5 × 10−12 (n = 25) in the high bone strength geno-
type (GG/GG).
Allelic imbalance
To reinforce the observation and to demonstrate if the 
effect was a cis or trans effect, expression of each allele 
in heterozygotes was examined. In heterozygotes from 
the same generation for which CBS expression in bone 
was measured (Population 4), the relative expression of 
alleles AA and GG was significantly different (P < 0.001). 
The expression of allele AA was much higher than that 
of allele GG (0.90 ± 0.01 versus 0.10 ± 0.01; n = 10). This 
suggested that expression of allele AA was ~ 9 times that 
of allele GG within an animal.
Table 3 Summary statistics for the animals segregating at SNPs Ost106225194 and Ost112522587
All the bone measurements were made on the left tibia mid-shaft. The AA/AA genotype is the genotype associated with lower bone strength. aN = 36; bN = 25
Genotype at Ost106225194 and Ost112522587 aAA/AA bGG/GG P value
Egg shell thickness (mm) 0.175 ± 0.012 0.197 ± 0.011 0.23
Body weight (g) 1599 ± 19 1600 ± 28 0.97
Total eggs 301.5 ± 2.7 303.0 ± 3.3 0.62
Cortical bone density (units per  mm3) 0.045 ± 0.002 0.050 ± 0.002 0.09
% as cortical bone 42.44 ± 0.85 44.46 ± 1.427 0.20
Cortical bone volume  (mm3) 38.30 ± 1.80 33.27 ± 1.70 0.06
Medullary bone density (units per  mm3) 0.024 ± 0.001 0.032 ± 0.003 0.009
Medullary bone volume  (mm3) 42.59 ± 2.10 32.33 ± 1.62 0.001
Medullary area  (mm2) 16.47 ± 0.83 14.02 ± 0.71 0.044
Total area 2440 ± 65 2311 ± 46 0.155
Table 4 List of genes with significant expression differences in the tibia between hens segregating for markers defining 
good (n = 8) and poor (n = 8) bone strength
FDR false discovery rate, Chr chromosome, bp position on the galGal6 build of the starting point of the gene
Log fold change P value FDR Ensembl gene ID Chr bp Associated 
gene 
symbol
− 1.76 1.50E−48 1.83E−44 ENSGALG00000016196 1 111,011,709 CBS
− 0.53 1.02E−07 0.00062 ENSGALG00000022808 1 111,336,046 RRP1B
− 0.66 1.00E−06 0.00409 ENSGALG00000016200 1 111,210,236 SIK1
1.92 6.64E−06 0.01966 ENSGALG00000009639 4 24,961,239 DDX60
− 0.72 8.02E−06 0.01966 ENSGALG00000016048 1 108,339,080 PIGP
0
10
20
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40
Chromosome
1 2 3 4 5 7 11 20
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Fig. 3 Manhattan plot of the significance (−logP) of the difference 
in expression of genes in the tibia between hens segregating for 
markers defining good (n = 8) and poor (n = 8) bone strength. x‑axis: 
chicken chromosomes and distance along the chromosomes. The 
genes marked in red are those considered significant, the majority are 
in the region of the mapped QTL on chromosome 1
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Physico‑chemical measurements of bone, radiographic bone 
density and plasma homocysteine from Population 5
To probe further into the underlying physiology and 
chemistry of the effect of the different alleles, we carried 
out a detailed examination of circulating homocysteine 
and of bone properties in the alternative genotypes. In 
a sample from Population 5, hens homozygous for the 
alternative alleles at the CBS gene displayed several sta-
tistical differences in bone quality (Table 5). While there 
was no difference in the gross measures of mechanical 
bone strength, there was a significantly higher circulat-
ing level of homocysteine at 48 and 70  weeks of age in 
hens with the AA/AA genotype. The AA/AA genotype 
is associated with lower bone quality. Several morpho-
metric and physico-chemical measurements differed 
significantly in this population. In particular, the cortical 
bone density, its degree of mineralization  (PO4/Amide I), 
cross-linking of collagen LNK 1660/1690, degree of crys-
tal orientation (inversely related to AngSpread002 and 
crystallinity index CI 1030/1020) were lower, whereas the 
amount of carbonate in bone mineral was higher in hens 
with the AA/AA than in those with the GG/GG genotype 
(Table 5). In contrast, there were no effects in the degree 
of medullary bone mineralization or chemical composi-
tion and, as in our previous observations, there was no 
difference in egg production or eggshell strength between 
the genotypes (Table 5).
Differences in the CBS sequence between the two genotypes 
and amino acid coding consequences
Using the NGS data, it was possible to build on the CBS 
predicted sequence, ENSGALT00000026110, and to 
determine the sequence of the two genotypes. This data 
defined a slightly longer 3′ end in the transcript than in 
the database and suggested a transcription start site that 
corresponded to the second predicted exon.
The sequence was submitted to ENSEMBL (EMBL 
Accession number LR588428). Using this information, 
the coding sequence was predicted to have 524 amino-
acids. There were nine SNPs in the cDNA that formed 
Table 5 Values for plasma homocysteine concentration at 48 and 70 weeks of age, production data, radiographic density, 
mechanical and physicochemical bone properties measured at 70 weeks of age between CBS genotype Ost106225194/
Ost112522587 (AA/AA vs. GG/GG) in Population 5
Trait AA/AA mean se GG/GG mean se P value df
Radiographic, mechanical, metabolite and production data
 Body weight Body weight (g) 1638 24 1603 24 0.291 1,64
 Egg traits Egg number 282.3 1.8 276.0 2.3 0.574 1,64
Egg breaking strength (48 wk of age) 40.1 0.9 40.4 1.3 0.508 1,61
 Plasma homocysteine Homocysteine 48 wk of age (µM/L) 18.64 0.55 16.68 0.64 0.024 1,52
Homocysteine 70 wk of age (µM/L) 19.13 0.46 17.18 0.63 0.016 1,64
Detailed morphometry and physicochemical analysis
 Bone type
  Whole tibia Breaking strength (N) 228.1 6.6 228.2 9.0 0.998 1,36
  Whole tibia Stiffness (Nm) 316,939 8456 322,940 9526 0.64 1,36
  Whole tibia Density (mm Al equiv/mm3) 1.60 0.01 1.61 0.01 0.412 1,36
% cortical bone 56.84 2.33 50.84 2.30 0.075 1,36
 Tibia cortical
  Tibia cortical Density (mmAl equiv/mm3) 0.018 0.001 0.022 0.001 0.024 1,36
  Tibia cortical MinCO3 1415 0.209 0.003 0.170 0.003 < 0.001 1,36
  Tibia cortical CI 1030/1020 0.584 0.004 0.633 0.007 < 0.001 1,36
  Tibia cortical PO4/Amide I 3.97 0.11 6.40 0.12 < 0.001 1,36
  Tibia cortical LNK 1660/1690 2.54 0.12 4.17 0.19 < 0.001 1,36
  Tibia cortical AngSpread 002 54.9 0.91 49.4 0.66 0.004 1,35
  Tibia cortical FWHM002 0.45 0.01 0.46 0.017 0.842 1,36
  Tibia medullary Density (mmAl equiv/mm3) 0.025 0.003 0.024 0.002 0.743 1,36
  Tibia medullary MinCO3 1415 0.18 0.03 0.16 0.02 0.576 1,36
  Tibia medullary CI 1030/1020 0.77 0.022 0.73 0.02 0.149 1,36
  Tibia medullary PO4/Amide I 1.17 0.09 1.25 0.10 0.585 1,36
  Tibia medullary LNK 1660/1690 3.20 0.09 3.20 0.07 0.998 1,36
  Tibia medullary FWHM002 0.58 0.03 0.56 0.02 0.425 1,35
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two haplotypes. These were previously described and 
can be found in dbSNP as rs317751309, rs736880045, 
rs315389726, rs314405634, rs314750178, rs316841302, 
rs15382187, rs317686139 and are determined in the 
sequence LR588428 to be synonymous. The excep-
tion was an amino-acid altering the SNP at posi-
tion 111,013,071 (galGal6) and at position 1579 in the 
sequence LR588428, which is annotated as rs316554658. 
This alters amino-acid 498 in the predicted CBS protein 
from a lysine (K) AAA to a glutamine (Q) CAA. These 
are respectively a charged and an uncharged but polar 
amino-acid. The lysine version is associated with the high 
bone strength genotype. The SNP rs316554658 was geno-
typed using RFLP as described above.
CBS enzyme activity assay in livers of embryos expressing 
protein from allelic variants
The Vmax and Km values were derived from samples 
taken from individual embryos that were homozygous for 
the amino-acid difference in the CBS sequence. We found 
no statistical difference in the activity of CBS allozymes 
measured in the liver of embryos homozygous for the 
amino-acid 498 coding difference. The kinetic parameters 
for the two allozymes were; lysine form Km, 0.51 ± 0.10, 
n = 6; glutamine form Km, 0.62 ± 0.13, n = 9 and lysine 
form Vmax, 107.9 ± 44.0, n = 6; glutamine form Vmax, 
157.4 ± 52.4, n = 9.
Discussion
Our results provide strong evidence that differences in 
the sequence surrounding the CBS gene are responsi-
ble for the observed phenotypic effects of the QTL on 
bone quality that was previously observed [16] and fine-
mapped in the current study. Specifically, the difference 
in expression between individual hens that carry differ-
ent combinations of the alleles is persuasive. There are a 
number of reasons, besides the obvious large difference 
in expression, which lead us to this conclusion. Cysta-
thione beta synthase has a key role in the methionine 
cycle as part of the one-carbon metabolic cycle in the 
production of sulphur-containing-amino-acids and is 
involved through its substrate in bone health [41]. CBS 
acts on its substrate, homocysteine, to regulate the con-
servation of methionine or the synthesis of cysteine via 
the trans–sulfuration pathway. The CBS gene has been 
reported to be highly expressed in embryonic and post-
natal bone [42] and there is considerable evidence that 
high homocysteine levels, may affect collagen cross-link-
ing and hence osteoporosis e.g. [43–45]. However, there 
is limited evidence to support any specific mechanism. 
Early studies suggested that high levels of homocyst-
eine resulted in higher solubility of collagen from a small 
number of affected individuals [46] and it is suggested 
that the mechanism may be a decrease in the activity of 
lysyl oxidase, which catalyses the crosslinking of collagen 
observed in  vivo in chicks [47]. However the effect was 
not observed in vitro, so the inhibition was not assumed 
to be direct [47].
There were other genes for which the fold change in 
expression between the genotypes was much less than 
that for CBS, three at the same locus as CBS on chromo-
some 1 and one on chromosome 4. Ribosomal RNA pro-
cessing 1B (RRP1B) is involved in ribosomal production 
but the literature focuses on its effects on extracellular 
matrix gene expression, tumor growth, and metastasis of 
cancer cells [48]. There are no reports of effects on bone 
although the extracellular matrix can of course include 
collagens. Salt inducible kinase 1 (SIK1) plays a role in 
conserved signal transduction pathways and may be part 
of a mechanism that maintains sodium balance in cells 
[49]. There is one report that suggests that it may play a 
role in osteoclast differentiation [50]. Phosphatidylinosi-
tol glycan anchor biosynthesis class P (PIGP) is a compo-
nent involved in the catalysis of glycolysis of proteins. We 
found no reports of a role in bone, but it is involved in 
blood cell glycolysis. The gene that was not at the locus 
on chromosome 1 was DExD/H-box helicase 60 (DDX60) 
and is principally recognised as an RNA binding mol-
ecule with anti-viral properties, but it has also been men-
tioned as a potential candidate for osteoporosis in a study 
on human monocytes [51].
Since we started with the discovery of a QTL in an F2 
population, we fine mapped the locus by returning to the 
founder population from which the high and low bone 
strength hens used in the cross were divergently selected. 
This allowed us to benefit from access to more recom-
binants. The same denser marker set was also used in the 
original F2 population and both approaches, as expected, 
identified a similar region.
The SNPs at the QTL were highly significantly asso-
ciated with tibia strength, with an additive effect of ~ 8 
Newton in breaking strength. This represents a large 
effect given a population mean for breaking strength 
of ~ 200 Newton. As expected for a genuine QTL, the 
addition of more markers in the F2 population improved 
the confidence of the result and therefore narrowed 
down the region. The QTL seems to be located on chro-
mosome 1 between 104.1 and 110.4  Mb on the galGal6 
assembly, whereas the flanking markers from the F2 pop-
ulation put the location at galGal6, Chr 1: 107.0-113.1 
for bone index and the bone index component, tibiotar-
sus breaking strength, although the estimated QTL peak 
position for the humerus breaking strength was galGal6, 
Chr 1: 90.2  Mb. The positions for the bone index and 
tibiotarsus QTL were strongly supported by the evi-
dence from the NGS expression data from mid-shaft tibia 
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from individuals with the Ost112522587/Ost106225194; 
AA/AA vs. GG/GG genotypes. Between the two geno-
types, we observed a group of genes with differences in 
expression that clustered around the gene with the larg-
est expression difference, CBS on chromosome 1 (gal-
Gal6, Chr 1: 111,011,730-111,028,603).
Expression data from heterozygotes for the low and 
high bone strength alleles showed allelic imbalance in 
the expression of CBS. This clearly indicated that the dif-
ference in expression was due to a cis-acting effect and 
not a trans-acting effect. In other words, it was unlikely 
that there was any involvement of a transcription fac-
tor transcribed from the region, acting on expression, as 
this would affect both alleles. In a complementary paper, 
we have identified a region of six tandem repeats in the 
promoter region of the CBS gene, which resulted in dif-
ferences in the level of methylation and transcriptional 
activity, and which segregates with the alternative geno-
types [32]. This may explain the differences in expression.
However, applying Occam’s razor, the simplest pos-
sibility for the observed differences in bone strength 
between the genotypes might be the difference in the 
predicted amino-acid sequence of the CBS gene at posi-
tion 498 from a lysine (K) to a glutamine (Q). Differ-
ences in expression could be the result of differences in 
feedback mechanisms if the enzyme activity was more 
or less active than the ‘wild type’ gene and protein. 
However, the results from the allelic imbalance study 
does not support the hypothesis that the observed 
effects were due to differences in feedback because of a 
faulty copy of the CBS enzyme. If a faulty copy of CBS 
was present, we would expect both copies to be equally 
affected by any feedback in a heterozygous individual 
and this was not the case. Of course, it could be that 
a combination of differences in the enzyme and a site 
in the promoter or enhancer through which the feed-
back mechanism works could be linked, but this seems 
less likely. Finally and more directly, we did not observe 
a difference in the activity of the two allozymes when 
they were tested. The chicken and the turkey genomes 
predict a glutamine (Q) at position 498 in the CBS pro-
tein, and glutamine has a non-charged polar side chain. 
Lysine (K), which has a charged side chain seems uni-
versal in predictions from other bird genomes. Lysine 
is also present in the chicken at this position when 
the glutamine codon is not present, as we have seen 
in this study. Reptiles feature glutamine (Q) or aspar-
tic acid (D) at this position in the CBS protein; these 
amino-acids possess a charged side chain with a nega-
tive charge. In mammals, it seems that threonine (T), 
another non-charged polar side chain amino-acid, 
is almost universal. Therefore, there is no indication 
that the charge at the position is conserved or that the 
difference in charge at this position might lead to a 
large effect on the enzyme’s activity. The results of the 
assays of enzyme activity in our study confirmed this 
with neither Vmax nor Km differing between the forms.
The level of plasma homocysteine, which is the sub-
strate for the CBS enzyme, differed significantly between 
the genotypes at 48 and 70  weeks of age, with plasma 
concentrations of homocysteine being about 2 µMol/L 
higher for AA hens than for GG hens at both ages. The 
difference is relatively small (~ 10%), in comparison to 
the difference in expression of the gene that is about 
nine-fold. In a study on human patients, in which groups 
from the extreme ends of the observed range were con-
stituted, the means for plasma homocysteine were 7 and 
28 μMol/L [45]. In our population, the maximum and 
minimum levels of homocysteine observed were 6 and 
26 μMol/L. If we used a similar approach to that of the 
human study, the extreme groups would have means of 
12 and 23 μMol/L, respectively. Therefore, the distribu-
tion of homocysteine values in the plasma from a nor-
mal population of chickens varies to a similar extent 
to that observed in humans. In humans, the correla-
tions observed between plasma homocysteine and col-
lagen cross-links [45] were across a much larger range 
of plasma homocysteine concentrations than what we 
observed in this study.
Therefore, contrary to what was expected, we observed 
both higher gene expression and higher homocysteine 
levels in the plasma of carriers of the AA allele associ-
ated with lower bone strength. At least, this is consistent 
with the observation that higher plasma homocysteine is 
associated with poorer bone quality. Since we have estab-
lished that there is no large difference in the activity of 
the enzyme between genotypes, we could expect higher 
gene expression to be correlated with increased protein 
activity and a potential reduction in the substrate homo-
cysteine [35]. Certainly, the presence of inactivating 
mutations in the CBS gene results in hyperhomocysteine-
mia [52]. It is also stated that mutations in CBS result in 
only mild increases in plasma homocysteine but these are 
more evident after a methionine load, with more marked 
effects being observed in defects of the re-methylation 
pathway [53].
Across the different analyses performed in this paper, 
we see a consistent effect of the GG genotype being asso-
ciated with greater bone strength. The exceptions were 
the analyses involving small numbers of hens, but this is 
almost certainly an effect of power. For example, for the 
samples used for NGS, the difference in cortical den-
sity tended to show a denser structure only for the GG 
genotype although the medullary bone was significantly 
denser in individuals with the GG genotype. However, 
there was a very clear effect on gene expression.
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Similarly, in the samples for which we examined 
the physicochemical properties of the bone between 
genotypes, we did not observe a significant effect on 
the bone mechanical properties but there were clear 
effects on the bone mineral chemistry and structure 
properties. Specifically, there was a higher degree of 
mineralization and higher degree of crystal orientation 
in cortical bone in individuals with the GG genotype, 
which was accompanied by lower  MinCO3 1415 in the 
tibia cortical bone. All these characteristics are typical 
of more mature bone, which has a higher degree of min-
eralization. This could be caused by a decreased turno-
ver rate that slows down the renewal of bone tissue [37, 
54]. There was also more crosslinking of collagen in the 
tibial cortical bone (LNK 1660/1690), which is charac-
teristic of older bone tissue. This suggests that the bone 
from the stronger genotype was associated with greater 
mineralisation, which is consistent with its higher 
density, the bone is also more mature, possibly with a 
higher degree of cross-links in the collagen which is 
not favoured by high homocysteine levels and therefore 
agrees with the observed lower plasma homocysteine 
[45]. Mineralization of the bone organic matrix occurs 
via the oriented nucleation of apatite crystals within 
the collagen fibre gaps as well as in the outer surface of 
collagen fibrils [55]. Any change in collagen structure 
caused by different levels of homocysteine could impact 
the mineralization of bone as in osteomalicia or osteo-
genesis imperfecta, which are caused by an alteration of 
collagen structure and produce abnormal mineraliza-
tion of the organic matrix [38, 56, 57].
These differences in bone properties are in contrast to 
the observations made between the divergently selected 
lines that were used to create the original F2, which were 
derived from the same line [37]. Between these lines 
there were no effects, although exercise did result in 
changes to the physico-chemical attributes of the bone 
[37], many of which are similar to those observed in this 
study, including the increased cross-linking. However, in 
that study the bones were sampled from hens that prob-
ably differ at many genetic loci as they were selected on 
the trait, not on a specific genotype. Whereas, in the 
samples examined in our study for the physico-chemical 
attributes of the bone, the hens were selected on a single 
genetic locus. Although the locus explained a relatively 
large effect, this was still small compared to the differ-
ence between the selected lines that gave rise to the F2 
individuals that were initially used to discover the QTL 
[8]. Indeed this exemplifies the problems of studying 
the individual locus underlying variation in a quantita-
tive trait. Even if the locus effect is relatively large, it is 
still likely to reach a magnitude that, for many measure-
ments related to the trait, would require extremely large 
numbers of animals to resolve at a physiological or bio-
chemical level how exactly the genetic locus exerts its 
effect.
There are a number of independent studies that have 
identified genetic loci for bone quality by using mainly 
crosses between fast and slower growing chicken strains 
with a risk of confounding effects of body weight; these 
studies include QTL that show relatively wide confi-
dence limits, some which coincide with the QTL studied 
in this manuscript [58]. Our study and other previously 
published ones have located a number of loci across the 
genome, which are potential candidates for bone qual-
ity, some of which may be relevant to layers, often fea-
turing bone density or mineral content [12, 13, 58–60]. 
Although some report QTL on chromosome 1, these 
do not appear to coincide with the QTL that we fine-
mapped in this study [61, 62]. Using a genome-wide 
association approach in one of the populations in this 
study, loci with a larger effect than the CBS loci have 
been observed, which suggests we can make progress in 
finding the underlying mechanism for these loci if large 
enough samples can be assembled [63].
Conclusions
We have confirmed and fine-mapped a genetic locus 
that affects the mechanical and physico-chemical prop-
erties of bone in laying hens. The physico-chemical 
properties of the bones from the two genotypes sug-
gest that greater mineralisation and maturity of colla-
gen cross-linking may be responsible for the improved 
quality of bone. We have identified a gene that encodes 
an enzyme, i.e. the CBS gene, which shows significantly 
different levels of expression between genotypes at 
the QTL. Adjacent genes to CBS are also differentially 
expressed, which suggests that a cis-acting enhancer 
operates at the locus. The genotype associated with 
higher expression of the CBS gene and poorer bone 
quality shows a small but significantly increased 
expression in the enzyme’s substrate, homocysteine. A 
number of studies have shown effects of raised plasma 
homocysteine in relation to poor bone quality but the 
effects reported here are small by comparison to those 
studied in humans. Although there are differences in 
the CBS protein sequence at one amino-acid, we cannot 
detect a difference in enzyme activity that could explain 
the observed phenotype in bone quality, and the dif-
ference in expression of the gene and the effect on the 
substrate concentration are not consistent. Therefore, 
although we have confirmed and extended the obser-
vations on this locus and have revealed the underly-
ing cause of the phenotype, which is a localised region 
of gene expression differences, we cannot say that we 
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have proven that CBS is the gene responsible. It may be 
necessary to look at other genes in the region to answer 
the question of which gene or genes make a difference 
to bone quality. From a practical point of view, in the 
meantime, markers at this locus can be used to improve 
bone quality and nutritional interventions to modify 
homocysteine levels and thus improve bone quality are 
possible.
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